NL
Nisa Leung
Managing Partner at Qiming Venture Partners\
United States
Overview
Nisa Leung is the Managing Partner at Qiming Venture Partners and a Forbes Midas Lister. She has made significant investments in various companies across sectors like Medical Devices, Consumer Health, and Health IT, including companies like Thorough Future, GenEditBio, and CureGenetics. Her career highlights include serving on the board of directors for Hong Kong Exchanges and Clearing Limited and making strategic investments in innovative healthcare and biotechnology companies.
Work Experience
Board Member / Investor
2019 - Current
Investor
2024
Investor
2024
Emulate creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
Raised $271,339,991.00 from Qiming Venture Partners.
Board director / Investor
2024
Board director / Investor
2023
Investor
2023
Attovia Therapeutics develops a pipeline of biotherapeutics for immune-mediated diseases.
Raised $165,000,000.00 from Marshall Wace, Redmile Group, Nextech Ventures, EcoR1 Capital, Logos Capital, venBio Partners, Illumina Ventures, Goldman Sachs Asset Management, Frazier Life Sciences and Cormorant Asset Management.
Board Member / Investor
2023
Board Member / Investor
2022
Board director / Investor
2022
Investor
2022
Curie.Bio is a founder-focused seed-stage venture capital firm.